Actively Recruiting
Clinical Characteristics of Small Intestinal Bacterial Overgrowth in Individuals with Abdominal Distention
Led by Shandong University · Updated on 2024-12-12
402
Participants Needed
1
Research Sites
74 weeks
Total Duration
On this page
Sponsors
S
Shandong University
Lead Sponsor
Q
Qilu Hospital of Shandong University (Qingdao)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Abdominal distention represents a prevalent clinical manifestation characterized by an unclear etiology and pathogenesis. This symptomatology is frequently observed in various conditions, including small intestinal bacterial overgrowth (SIBO) and abnormal orocecal transit time (OCTT). The utilization of the breath test as a non-invasive diagnostic approach has become widespread in recent years for identifying SIBO and abnormalities in OCTT. In this study, the prevalence of SIBO and OCTT irregularities in individuals presenting with abdominal distention was ascertained through the implementation of the breath test. Furthermore, the correlation between abdominal distention and SIBO/OCTT was analysed to enhance the elucidation of the underlying etiology of abdominal distention. These findings aim to offer valuable insights for refining clinical comprehension and strategies related to the diagnosis and treatment of abdominal distention.
CONDITIONS
Official Title
Clinical Characteristics of Small Intestinal Bacterial Overgrowth in Individuals with Abdominal Distention
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 to 70 years
- Patients with abdominal bloating and/or abdominal distension as their main complaint
- Patients with abdominal distension more prominent than other symptoms
You will not qualify if you...
- Pregnant or lactating patients
- History of gastrointestinal cancer or gastrointestinal surgery
- Patients with food intolerance or diagnosed or suspected lactose intolerance
- Patients with diseases of the urinary, immune, nervous, mental, or other non-digestive systems
- Patients who used antibiotics, probiotics, or had endoscopic exams within two weeks
- Patients who used motility enhancers, secretory enhancers, antifoaming agents, spasmolytics, opioids, or antidepressants within the past week
- Patients unwilling or unable to give informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Gastroenterology Department of Qilu Hospital
Jinan, Shandong, China, 250012
Actively Recruiting
Research Team
X
Xiuli Zuo, MD,PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here